Dopamine D1 and D2 receptor binding sites in brain samples from depressed suicides and controls

Brain Research

Volumn 752, Issue 1-2, 1997, Pages 227-233

  Bowden, Christine ^a,e   Theodorou, Andreas E ^b   Cheetham, Sharon C ^c   Lowther, Sandra ^a   Katona, Cornelius L E ^d   Crompton, M Rufus ^a   Horton, Roger W ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b N East Surrey College of Technology   (United Kingdom)

^c ABBOTT LABORATORIES   (United States)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^e Novo Nordisk Ltd   (United Kingdom)

Author keywords

antidepressant drug; depression; dopamine D1 receptor binding site; dopamine D2 receptor binding site; neuroleptic; post mortem brain tissue; suicide

Indexed keywords

ANTIDEPRESSANT AGENT; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; NEUROLEPTIC AGENT; RADIOLIGAND;

ADULT; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; HUMAN TISSUE; MALE; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PUTAMEN; RECEPTOR BINDING; SUICIDE; ADOLESCENT; AGED; BINDING SITE; BRAIN; DRUG EFFECT; METABOLISM; MIDDLE AGED; REFERENCE VALUE; VIOLENCE;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; BINDING SITES; BRAIN; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; REFERENCE VALUES; SUICIDE; VIOLENCE;

EID: 0030615283     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)01460-6     Document Type: Article

References (51)

1. Amsterdam, J.D., Dunner, D.L., Fabre, L.F., Kiev, A., Rush, A.J. and Goodman, L.I., Double-blind, placebo-controlled, fixed dose trial of minaprine in patients with major depression, Pharmacopsychiatry, 22 (1989) 137-143.
2. Asberg, M., Träskman, L. and Thorén, P., 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor?, Arch. Gen. Psychiatry, 33 (1976) 1193-1197.
3. Banki, C.M., Correlation between CSF metabolites and psychomotor activity in affective disorders, J. Neurochem., 28 (1977) 255-257.
4. Berger, P.A., Faull, K.F., Kilkowski, J., Anderson, P.J., Kraemer, H., Davis, K.L. and Barchas, J., CSF monoamine metabolites in depression and schizophrenia, Am. J. Psychiatry, 137 (1980) 174-180.
5. Beskow, J., Gottfries, C.G., Roos, B.E. and Winblad, B., Determination of monoamines and monoamine metabolites in the human brain: post-mortem studies in a group of suicides and in a control group, Acta Psychiatr. Scand., 53 (1976) 7-20.
6. Bowers, M.B., CSF 5-HIAA and HVA following probenecid in unipolar depressives treated with amitriptyline, Psychopharmacology, 23 (1972) 26-33.
7. Bowers, M.B., Heninger, G.R. and Gerbode, F., Cerebrospinal fluid 5-hydroxyindoleacetic acid and homovanillic acid in psychiatric patients, Int. J. Neuropharmacol., 8 (1969) 255-262.
8. Casper, R.C., Davis, J.M., Pandey, G.N., Garver, D.L. and Dekirmenjian, H., Neuroendocrine and amine studies in affective illness, Psychoneuroendocrinology, 2 (1977) 105-113.
9. Celesia, C.G. and Wanamaker, W.M., Psychiatric disturbances in Parkinson's disease, Dis. Nerv. Syst., 33 (1972) 577-583.
10. Checkley, S.A., Corticosteroid and growth hormone responses to methylamphetamine in depressive illness, Psychol. Med., 9 (1979) 107-116.
11. 2 receptor binding sites in depressed suicide victims, Brain Res., 443 (1988) 272-280.
12. 2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic function, J. Neural Transm., 102 (1995) 35-46.
13. Clow, A., Jenner, P., Theodorou, A. and Marsden, C.D., Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six months, Nature, 278 (1979) 59-61.
14. Clow, A., Theodorou, A.E., Jenner, P. and Marsden, C.D., Changes in rat striatal dopamine turnover and receptor activity during one years neuroleptic administration, Eur. J. Pharmacol, 63 (1980) 135-144.
15. Colonna, L., Petit, M. and Lepine, J.P., Bromocriptine in affective disorders: a pilot study, J. Affect. Disord. 1 (1979) 173-177.
16. Coppen, A. and Ghose, K., Peripheral α-adrenoceptor and central dopamine receptor activity in depressive patients, Psychopharmacology, 59 (1978) 171-177,
17. De Keyser, J., Subtypes and localisation of dopamine receptors in human brain, Neurochem. Int., 22 (1993) 83-93.
18. 3H]SCH23390 binding and DA-sensitive adenylate cyclase in limbic system, Eur. J. Pharmacol., 167 (1989) 299-303.
19. DeMontis, G.M., Devoto, P., Gessa, G.L., Meloni, D., Porcella, A., Saba, P., Serra, G. and Tagliamonte, A., Central dopaminergic transmission is selectively increased in the limbic system of rats chronically exposed to antidepressants, Eur. J. Pharmacol., 180 (1990) 31-35.
20. Dunnett, C.W., New cables for multiple comparisons with a control, Biometrics, 20 (1964) 482-491.
21. Feighner, J.P., Meredith, C.H., Stren, W.C., Hendrickson, G. and Miller, L.L.. A double-blind study of bupropion and placebo in depression. Am. J. Psychiatry, 141 (1984) 525-529.
22. Feinberg, M., Bupropion: new therapy for depression, Am. Fam. Practitioner, 41 (1990) 1787-1790.
23. Goodwin, F.K., Post, R.M., Dunner, D.L. and Gordon, E.K., Cerebrospinal fluid amine metabolites in affective illness: the probenecid technique, Am. J. Psychiatry, 130 (1973) 73-79.
24. Hess, EJ., Bracha, H.S., Kleinman, J.E. and Creese, I., Dopamine receptor subtype imbalance in schizophrenia. Life Sci., 40 (1987) 1487-1497.
25. 3H]SCH23390 binding sites in rat striatum and the limbic system, Eur. J. Pharmacol, 139 (1987) 163-169.
26. 3H]piflutixol binding sites in the rat striatum, Eur. J. Pharmacol., 109 (1985) 131-132.
27. Koide, T. and Matsushita, H., An enhanced sensitivity of muscarinic cholinergic receptors associated with dopaminergic receptor subsensitivity after chronic antidepressant treatment. Life Sci., 28 (1981) 1139-1145.
28. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J., Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193 (1951) 265-275.
29. Mackay, A.V.P., Iversen, L.L., Rossor, M., Spokes, E., Bird, E., Arregui, A., Creese, I. and Snyder, S.H., Increased brain dopamine and dopamine receptors in schizophrenia, Arch. Gen. Psychiatry, 39 (1982) 991-997.
30. 1 binding is not altered by antidepressant treatment including ECS and sibutramine hydrochloride, Br. J. Pharmacol., 95 (1988) 896P.
31. Mendels, J., Frazer, A., Fitzgerald, R.G., Ramsey, T.A. and Stokes, J.W., Biogenic amine metabolites in the cerebrospinal fluid of depressed and manic patients, Science, 175 (1972) 1380-1382.
32. Moses, S.G. and Robins, E., Regional distribution of norepinephrine and dopamine in brains of depressive suicides and alcoholic suicides, Psychopharmacol. Commun., 1 (1975) 327-337.
33. Nordin, C., Siwers, B. and Bertilsson, L., Bromocriptine treatment of depressive disorders. Clinical and biochemical effects, Acta Psychiatr. Scand., 64 (1981) 25-33.
34. Nurnberger, J.L., Gershon, E.S., Simmons, S., Ebert, M., Kessler, L.R., Dibble, E.D., Jimerson, S.S., Brown, G.M., Gold, P., Jimerson, D.C., Guroff, J.J. and Storch, F.I., Behavioural, biochemical and neuroendocrine responses to amphetamine in normal twins and "well-state" bipolar patients, Psychoneuroendocrinology, 7 (1982) 163-176.
35. Owen, F., Crow, T.J., Poulter, M., Cross, A.J., Longden, A. and Riley, G.J., Increased dopamine-receptor sensitivity in schizophrenia. Lancet, II (1978) 223-225.
36. 3H]spiperone binding in the rat striatum, Cell. Mol. Neurobiol., 12 (1992) 597-606.
37. Pare, C.M.B., Yeung, D.P.H., Price, K. and Stacey, R.S., 5-Hydroxytryptamine, noradrenaline and dopamine in brainstem, hypothalamus and caudate nucleus of controls and of patients committing suicide by coal gas poisoning, Lancet, II (1969) 133-135.
38. 2 dopamine receptor density in psychotic and nonpsychotic patients with bipolar disorder, Arch. Gen. Psychiatry, 52 (1995) 471-477.
39. Post, R.M., Gerner, R.H., Carman, J.S., Gillin, J.C., Jimerson, D.C., Goodwin, F.K. and Bunney, W.E., Effects of a dopamine agonist piribedil in depressed patients, Arch. Gen. Psychiatry, 35 (1978) 609-615.
40. Randrup, A., Munkvad, I., Fog, R., Gerlach, J., Molander, L., Kjellberg, B. and Scheel-Kruger, J., Mania, depression and brain dopamine. In: W.B. Essman and L. Valzelli (Eds.), Current Developments in Psychopharmacology, Vol. 2, Spectrum Publications, New York, 1975, pp. 206-248.
41. Robins, A.M., Depression in patients with Parkinsonism, Br. J. Psychiatry, 128 (1976) 141-145.
42. Roy, A., DeJong, J. and Linnoila, M., Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients: a 5-year follow-up study, Arch. Gen. Psychiatry, 46 (1989) 609-612.
43. Roy, A., Pickar, D., Linnoila, M., Doran, A.R., Ninan, P. and Paul, S.M., Cerebrospinal fluid monoamine and monoamine metabolite concentrations in melancholia. Psychiatry Res., 15 (1985) 281-292.
44. Sachar, E.J., Frantz, A.G., Altman, N. and Sassin, J., Growth hormone and prolactin in unipolar and bipolar depressed patients: responses to hypoglycemia and L-dopa, Am. J. Psychiatry, 130 (1973) 1362-1367.
45. SAS/STAT user's guide, SAS Institute Inc., Cary, USA, 1990.
46. Silverstone, T., Response to bromocriptine distinguishes bipolar from unipolar depression, Lancet, I (1984) 903-904.
47. Sjöström, R., 5-Hydroxyindoleacetic acid and homovanillic acid in cerebrospinal fluid in manic-depressive psychosis and the effect of probenecid treatment, Eur. J. Clin. Pharmacol., 6 (1973) 75-80.
48. Strange, P.G. (Ed.), Progress in Brain Research, Vol. 99, Dopamine receptors: structure and function. Elsevier. Amsterdam, 1993, pp. 167-179.
49. Toru, M., Watanabe, S., Shibuya, H., Nishikawa, H., Kurumaji, A., Takashima, M., Mataga, N. and Ogawa, A., Neurotransmitters, receptors and neuropeptides in post-mortem brains of chronic schizophrenic patients, Acta Psychiatr. Scand., 78 (1988) 121-137.
50. Van Scheyen, J.D., Van Praag, H.M. and Korf, J., Controlled study comparing nomifensine and clomipramine in unipolar depression, using the probenecid technique, Br. J. Clin. Pharmacol., 4 (1977) 179S-184S.
51. Young, J.P.R., Hughes, W.C. and Lader, M., A controlled comparison of flupenthixol and amitriptyline in depressed outpatients, Br. Med. J., 1 (1976) 1116-1118.